Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EGFR-IN-82 (Compound 8a) is a potent, orally active inhibitor of EGFR, exhibiting IC50 values of 0.09 nM for EGFR L858R/T790M/C797S and 0.06 nM for EGFR Del19/T790M/C797S. It lacks significant inhibitory effects on EGFR WT. Demonstrating anti-proliferative properties, EGFR-IN-82 also inhibits tumor growth in nude mice, rendering it applicable in non-small cell lung cancer research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | EGFR-IN-82 (Compound 8a) is a potent, orally active inhibitor of EGFR, exhibiting IC50 values of 0.09 nM for EGFR L858R/T790M/C797S and 0.06 nM for EGFR Del19/T790M/C797S. It lacks significant inhibitory effects on EGFR WT. Demonstrating anti-proliferative properties, EGFR-IN-82 also inhibits tumor growth in nude mice, rendering it applicable in non-small cell lung cancer research [1]. |
In vitro | EGFR-IN-82 (compound 8a), following a 72 hour exposure, significantly inhibited the growth of Ba/F3-EGFR Del19/T790M/C797S cells, with an IC50 value of 12.7 nM, yet exhibited no notable effect on the proliferation of A431 cells [1]. |
In vivo | EGFR-IN-82 (compound 8a) exhibits pharmacokinetic properties superior to Brigatinib [1]. When administered orally at doses of 15 - 30 mg/kg over 14 - 21 days, EGFR-IN-82 moderately inhibits tumor growth in a PC9-EGFR Del19/T790M/C797S xenograft mouse model and markedly inhibits tumor growth in a Ba/F3-EGFR Del19/T790M/C797S xenograft mouse model [1]. Pharmacokinetic analysis in Balb/C mice demonstrated the following parameters [1]: Route Dose (mg/kg), C max (ng/mL), AUC 0-t (ng/mL*h), AUC 0-∞ (ng/mL*h), t 1/2 (h), MRT (h), p.o. 5, 1574, 15375, 15632, 3.5, 6. |
Molecular Weight | 694.6 |
Formula | C32H41BrN9O2P |
CAS No. | 2568086-81-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EGFR-IN-82 2568086-81-5 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR inhibitor inhibit